Abstract The aims of this study were twofold. The first was to investigate the diagnostic performance of two biochemical markers, procalcitonin (PCT) and lipopolysaccharide-binding protein (LBP), considering each individually and then combined, for the postmortem diagnosis of sepsis. We also tested the usefulness of pericardial fluid for postmortem LBP determination. Two study groups were formed, a sepsis-related fatalities group of 12 cases and a control group of 30 cases. Postmortem native CT scans, autopsy, histology, neuropathology, and toxicology as well as other postmortem biochemical investigations were performed in all cases. Microbiological investigations were also carried out in the septic group. Postmortem serum PCT and LBP levels differed between the two groups. Both biomarkers, individually considered, allowed septic states to be diagnosed, whereas increases in both postmortem serum PCT and LBP levels were only observed in cases of sepsis. Similarly, normal PCT and LBP values in postmortem serum were identified only in non-septic cases. Pericardial fluid LBP levels do not correlate with the presence of underlying septic states. No relationship was observed between postmortem serum and pericardial fluid LBP levels in either septic or non-septic groups, or between pericardial fluid PCT and LBP levels.
Introduction
Reliable diagnosis of sepsis remains a major challenge for forensic pathologists despite extensive research and development in immunohistochemistry and postmortem biochemistry. Medical records are often unavailable when autopsy is performed, and macroscopic and microscopic data may be elusive. Much effort has therefore been directed toward identifying clinical biochemical parameters whose measurements in the forensic casework might provide additional information and represent a reliable tool for estimating the probability of sepsis as cause of death. Biochemical markers of inflammation and sepsis have mainly been tested in postmortem serum from femoral blood and experimentally measured in other biological substrates, such as pericardial fluid [1] , vitreous humor, cerebrospinal fluid [2] , and liver [3] , at times with promising results.
Several investigations in living people have confirmed the usefulness of C-reactive protein (CRP) and procalcitonin (PCT) as biochemical markers for the diagnosis of systemic inflammation and bacterial sepsis. In the forensic field, these parameters can easily be measured in peripheral and cardiac blood as well as in postmortem serum. Furthermore, they may be used for forensic purposes as in clinical practice. Nevertheless, the diagnostic power of these markers in detecting sepsis-related fatalities is somehow unsatisfactory. Indeed, some clinical studies have positively evaluated high plasma CRP levels in patients with infection and sepsis, whereas results from many other studies have failed to show the impact of elevated CRP levels for either the diagnosis of infection and sepsis or the assessment of sepsis severity [4, 5] . CRP plasma levels may furthermore remain elevated several days after elimination of the infectious focus and increased levels have been described in many noninfectious conditions, such as autoimmune and rheumatic disorders, acute coronary syndromes, and malignant tumors post-surgery [5] [6] [7] [8] .
PCT elevation may already be recognized just 2 h after endotoxemia or bacteremia [9, 10] . Nevertheless, as with CRP, there are a number of noninfectious causes that may result in increased PCT levels apart from bacterial infections, such as major surgery, severe trauma, exertional heat stroke, or burns [11] [12] [13] [14] [15] . Plasma concentrations observed under these conditions are not as high, however, as in patients with severe sepsis or septic shock [5] . Increased PCT values have also been described, together with other signs of systemic inflammation, in prolonged cardiogenic shock, likely in relation to endotoxin translocation after gastrointestinal perfusion impairment [16, 17] .
Lipopolysaccharide (LPS)-binding protein (LBP) was initially discovered by Tobias in 1986 as an acute-phase reactant binding the LPS of Gram-negative bacteria wall to form LPS-LBP complexes [18, 19] . Biochemically, LBP is a 50-kDa polypeptide, mainly synthesized in the hepatocytes and released into the bloodstream as a 58-60-kDa glycoprotein resulting from glycosylation. The human form consists of 452 amino acid residues in the mature protein with the typical 25-aminoacid signal sequence that characterizes secreted proteins.
LBP is constitutively present in serum at concentrations of 2-10 μg/ml. Levels may increase during the acute-phase reaction [20] to reach peaks of up to 200 μg/ml [21] .
Elevated LBP plasma levels have been described in earlyonset neonatal sepsis [22, 23] and in adults after extensive cardiothoracic surgical procedures [24, 25] . A clinical study performed by Meynaar et al. [24] concluded that PCT levels were more helpful than LBP values in differentiating sepsis from systemic inflammatory response syndrome (SIRS) in critically ill patients admitted to hospital.
In the field of forensic pathology, Reichelt et al. [25] monitored the postmortem course of three endogenous biomarkers, including LBP, in a series of sepsis-related fatalities and non-septic control individuals during the early postmortem period. They concluded that LBP levels higher than 10 μg/ml in peripheral and venous blood could be regarded as diagnostic hints for underlying sepsis in the deceased. This appeared especially significant when at least two measurements were performed at different postmortem times in order to estimate the most probable LBP level at death.
In the study herein presented, PCT and LBP levels were measured in postmortem serum from femoral blood and pericardial fluid in a series of sepsis-related fatalities and control individuals. The first objective of this study was to assess the diagnostic performance of both parameters, combined or individually considered, to detect sepsis-related fatalities. The second aim was to compare pericardial fluid to postmortem serum LBP levels to test the usefulness of pericardial fluid for biochemical investigations. Postmortem native CT scans, autopsy, histology, neuropathology, and toxicology as well as other postmortem biochemical analyses were performed in all cases selected for this study.
Material and methods

Subjects
Two study groups were formed: a sepsis-related fatalities group and a control group. The sepsis-related fatalities group consisted of 12 forensic autopsy cases (six males, six females, no children) with a mean age of 52.7 years (range 17-80 years).
None of the subjects included in this group had a documented diagnosis of sepsis in vivo and none had been admitted to the hospital prior to death. Medical records obtained prior to autopsies were consistent with the hypothesis that underlying bacterial sepsis might be at the origin of or contributing to death. Autopsies were ordered by the public prosecutor due to the unclear circumstances of death and the bodies were transferred to the medicolegal center.
For all cases included in this group, complete forensic autopsies were performed within 5-62 h after death (mean postmortem period 22.6 h), always preceded by native CT scans. Histology, neuropathology, and toxicology were performed in all cases as well as microbiological investigations on right cardiac blood.
Postmortem biochemical investigations were carried out on postmortem serum from femoral blood (procalcitonin, CRP, LBP, troponin I, NT-proBNP, tryptase, urea nitrogen, creatinine, and uric acid), whole blood (3-beta-hydroxybutyrate), vitreous humor (glucose, sodium, chloride), and pericardial fluid (procalcitonin, LBP).
The cause of death was attributed to multiple organ failure based on the results of postmortem investigations as well as the exclusion of other causes of death. Underlying bacterial septic states were postulated to be at the origin of the multiple organ failures. Descriptive characteristics of the investigated subjects and main postmortem investigation findings are reported in Table 1 .
The control group consisted of 30 forensic autopsy cases. None of the subjects included in this group had a documented, clinical diagnosis of sepsis in vivo and none had been admitted to the hospital prior to death. Complete forensic autopsies were performed between 8 and 51 h after death (mean 24.4 h), always preceded by native CT scans. Histology, neuropathology, and toxicology were performed in all cases, as well as biochemical analyses on postmortem serum from femoral blood, whole blood, pericardial fluid, and vitreous humor. Microbiology was not performed in any of the cases in this group.
Causes of death were determined to be drug intoxication (eight cases), drowning (two cases), positional asphyxia (one case), trauma post-traffic accident (five cases), stab wounds (four cases), gunshot wounds (five cases), and natural cardiac death (five cases).
Postmortem investigations failed to reveal findings consistent with the existence of underlying bacterial infections or septic states. Descriptive characteristics of the control group subjects, main postmortem investigation findings, and causes of death are reported in Table 2 .
Sample collection
Femoral blood and postmortem serum from femoral blood Using a sterile needle and syringe, postmortem blood samples were collected by aspiration through the femoral vein during the autopsy. Part of the sample was centrifuged immediately post-collection at 3,000×g for 15 min. After centrifugation, the separated supernatant (postmortem serum) was collected, stored in preservative-free tubes, and frozen at −20°C until analysis.
Right cardiac blood
The external side of the right atrium was sterilized by searing with a flamed scalpel blade. The cardiac blood was aspired with a syringe and stored in blood culture bottles (aerobic and anaerobic). The collected samples were immediately incubated at 37°C.
Pericardial fluid
Undiluted samples of pericardial fluid were collected immediately post-pericardium incision during autopsy. All samples were immediately centrifuged at 3,000×g for 15 min. After centrifugation, the separated supernatant was collected, stored in preservative-free tubes, and frozen at −20°C until analysis.
Laboratory assays
Determination of procalcitonin concentration PCT was measured with the commercially available immunoassays on the Roche Modular E170 analyzer (Roche Diagnostic, Mannheim, Germany). The results were expressed in micrograms per liter. The analytical sensitivity for PCT was 0.1 μg/l, according to manufacturer information.
Determination of LBP concentration
LBP was determined by chemiluminescent immunometric assay Immulite®2000 (Siemens Medical, Germany). The results were expressed in micrograms per milliliter. The analytical sensitivity for LBP was 0.2 μg/ml, according to manufacturer information.
Other analyses
Other biochemical analyses were performed according to the laboratory standards and internal quality control protocols.
Ethical considerations
All cases collected for this study underwent medicolegal autopsies requested by the public prosecutor. Biochemical analyses, including PCT, CRP, and LBP determinations, were performed as part of the medicolegal investigations and no further ethical permission was required to perform laboratory analyses.
Statistical analyses
The data were analyzed by using STATA statistical software package (STATA Corporation, College Station, TX, USA). Receiver operator characteristic (ROC) curves, sensitivity,
and specificity values were calculated to assess the performance of the selected biomarkers as diagnostic markers for sepsis. Diagnostic accuracy was determined by the area under the curves (AUC) of the studied markers. According to laboratory references, procalcitonin values were dichotomized into "non-septic values" (concentrations lower than 2 μg/l) and "septic values" (concentrations greater than 2 μg/l). Analogously, LBP values were dichotomized into "normal values" (concentrations lower than 10 μg/ml) and "increased values" (concentrations greater than 10 μg/ml).
Results
Descriptive characteristics of the studied subjects, laboratory results, causes of death, and statistical results are reported in Tables 1, 2 , and 3.
Postmortem serum
In the 12 cases included in the sepsis group, the cause of death was attributed to multiple organ failure based on the results of postmortem investigations as well as the exclusion of other causes of death. Underlying bacterial septic states were postulated as being at the origin of the multiple organ failures. Assuming that normal and pathological PCT and LBP blood levels in living people show similar ranges in postmortem serum from femoral blood, only one individual (case 4) among the sepsis-related fatalities presented a normal postmortem serum PCT value (0.06 μg/l), with an increased postmortem serum LBP level (15.4 μg/ml). Blood cultures revealed the presence of multiple Gram-positive-and Gramnegative bacteria. Histology showed the presence of multiple foci of polynuclear neutrophils in both lungs. According to medical records, the patient suffered from pneumonia and had received antibiotic treatment 5 days prior to death.
Conversely, one individual among the sepsis-related fatalities (case 1) presented a normal postmortem serum LBP value (6.1 μg/ml), whereas the postmortem serum PCT level was increased (23.37 μg/l). Increased levels of both postmortem serum PCT and LBP were observed in 10 out of 12 septic cases. In the 30 control cases, postmortem investigations failed to reveal findings consistent with the existence of underlying bacterial infections or septic states. Again, assuming that normal and pathological PCT and LBP blood levels in living people show similar ranges in postmortem serum from femoral blood, two cases were observed that revealed increased postmortem serum PCT values and normal LBP concentrations (case 29, drug intoxication, PCT 5.21 μg/l and LBP 5.0 μg/ml; case 30, positional asphyxia, PCT 8.26 μg/l and LBP 6.2 μg/ml;) and one case of drowning (case 28) showing a normal postmortem serum PCT value (0.06 μg/l) but an increased postmortem serum LBP level (12.2 μg/ml).
As expected, postmortem serum PCT levels were higher in the sepsis group and differed between the two groups, with only one false-negative case in the sepsis group (which conversely showed an increased LBP value) and two falsepositives in the control group (which conversely showed normal LBP values). However, assuming that there are a number of noninfectious situations that may result in increased PCT levels, one might speculate on the possibility that these two "false positive" septic cases were indeed "true negative" nonseptic cases, as confirmed by normal LBP values.
Similarly, postmortem serum LBP levels were higher in the sepsis group and differed between the two groups, with only one false-negative case in the sepsis group (which conversely showed an increased PCT value) and one falsepositive case in the control group (which conversely showed a normal PCT value).
None of the control cases showed increases in both marker values at the same time. PCT determination in postmortem serum in both septic and control groups allowed us to confirm the diagnostic accuracy of this biomarker in detecting sepsis-related fatalities (sensitivity 91.67 %, specificity 93.33 %, AUC 0.93). Similarly, LBP determination in postmortem serum in both studied groups also allowed septic states (sensitivity 91.67 %, specificity 96.67 %, AUC 0.96) to be identified.
Increases in both postmortem serum PCT and LBP levels were only observed in septic cases. Analogously, both normal PCT and LBP levels were only found in non-septic cases, thereby suggesting that converging PCT and LBP results represent a useful tool in confirming the septic nature of a specific case (sensitivity 83.33 %, specificity 100 %, AUC 0.99).
Pericardial fluid
Assuming that normal and pathological PCT and LBP blood levels in living people show similar ranges in postmortem pericardial fluid (concentrations greater than 2 μg/l for PCT and greater than 10 μg/ml for LBP), pericardial fluid PCT levels were higher in the sepsis group and differed between sepsis and control individuals (sensitivity 75.00 %, specificity 93.33 %, AUC 0.92).
Pathologically increased postmortem serum PCT levels in the sepsis group in 11 cases were reflected in pathologically increased pericardial fluid PCT levels in nine cases. Among the control cases, postmortem serum PCT levels below the detection limit in 28 cases were reflected in undetectable pericardial fluid levels in the same 28 cases. These data concur with those of Schrag et al. [1] who concluded that procalcitonin can be measured in pericardial fluid and provide useful information for forensic purposes when postmortem serum is unavailable.
Lastly, the results of the data analysis revealed that pericardial fluid LBP levels were similar in the studied groups. Postmortem serum and pericardial fluid LBP values in both septic and non-septic groups were incomparable, as well as pericardial fluid PCT and LBP levels (sensitivity 16.67 %, specificity 93.33 %, AUC 0.81), suggesting that the determination of LBP in pericardial fluid does not appear to be an alternative option should postmortem serum be unavailable.
Right cardiac blood
Since neither antemortem blood cultures nor documented diagnosis of sepsis in vivo were available for the cases included in the sepsis group, results obtained from microbiology were cautiously interpreted due to the possibility of postmortem contamination.
Discussion
The aim of this study was to investigate the diagnostic performance of two biochemical markers, PCT and LBP, combined or individually considered, to identify sepsis- related fatalities. We furthermore wished to test the usefulness of pericardial fluid for LBP determination. Concerning the first objective, the results of this study showed that postmortem serum PCT and LBP levels, individually considered, allow sepsis cases to be reliably detected. Additionally, increases in both parameters in postmortem serum were observed only in septic cases, suggesting that coherent PCT and LBP results can be used in forensic routine in order to corroborate the existence of underlying, bacterial septic states.
Reliable diagnoses of sepsis are of utmost importance in forensic pathology routine, firstly due to the lack of detailed medical records when bodies are admitted to the mortuary for medicolegal investigations, secondly because macroscopic and microscopic findings may be elusive or nonspecific. Thus, biochemical markers that could discriminate between sepsis-related fatalities and noninfectious SIRS would be of great importance in this field.
Several biochemical markers have been proposed in recent years as potential parameters differentiating between infectious and noninfectious SIRS in both clinical and forensic medicine [1] [2] [3] [26] [27] [28] [29] [30] [31] [32] . The discriminative value of CRP and interleukin-6 in distinguishing sepsis from noninfectious SIRS is somehow limited due to the fact that both biomarkers are nonspecific indicators of underlying inflammatory processes rather than bacterial sepsis [2, 29] .
PCT has been evaluated in multiple clinical settings as a laboratory tool in differentiating bacterial infections from other inflammatory states and infectious processes [33, 34] . Four meta-analyses have reported on PCT performance in the diagnosis of sepsis with conflicting results. Two studies suggested that PCT is superior to other biochemical parameters, whereas two other studies found PCT to have either a moderate or poor ability in identifying sepsis in critically ill, adult patients [35] [36] [37] [38] [39] .
In neonatal sepsis, PCT seems to better discriminate SIRS from sepsis as well as bacterial infections from non-bacterial infections in comparison with other biomarkers, though it is not statistically more accurate than CRP [23, 40] . Adequate laboratory diagnostics therefore represent a major requirement for improving the diagnosis of sepsis [41] .
Sepsis is not a single disease but rather a highly heterogeneous syndrome that is the final result of host and pathogen interactions triggering networks of biochemical mediators and inflammatory cascades. Clinical expression is therefore variable and severity is influenced by several factors including type of pathogen, infection site, clinical interventions, and host factors, such as genetics and baseline health [34] .
LBP belongs to the acute-phase proteins and is mainly synthesized by hepatocytes but by epithelial and muscle cells as well [23, 42] . LBP binds and recruits endotoxin to the surface of Gram-negative bacteria very early during infection. Under physiologic circumstances, LBP binds Gram-negative bacteria via the lipid A part of LPS, which mediates its binding to the CD14 cellular receptor molecule presented by monocytes and macrophages. This results in phagocytosis and clearance of these microorganisms [23, 43] . LBP plasma levels have been investigated in various human populations: in healthy subjects, LBP plasma concentrations range from 2 to 10 μg/ml [44] whereas very high plasma levels, exceeding 100 μg/ml, have been observed in patients with sepsis, SIRS, abdominal infections, ulcerative colitis, and many other diseases. Pavcnik-Arnol et al. [45] found that LBP was an early marker that differentiated between noninfectious SIRS and sepsis in critically ill neonates and children with high accuracy. The LBP cutoff value of >7.4 μg/ml identifying septic syndrome has been reported for newborns and is nearly identical for adults [46] .
In forensic pathology literature, no studies have been performed to compare the discriminative values of LBP and PCT for the postmortem diagnosis of sepsis-related fatalities. Reichelt et al. [25] investigated the postmortem behavior of LPB in two groups of septic and non-septic individuals and observed a decreasing trend of LBP postmortem serum levels in both groups with postmortem interval progression. The authors correlated such decreasing concentrations namely to the postmortem proteolysis of the molecule with the onset of significant hemolysis. Based on the results of their investigations, the authors concluded that LBP postmortem serum levels above 10 μg/ml could be considered diagnostic clues for underlying sepsis and proposed at least two measurements at different postmortem intervals to better estimate the most probable LBP level at the time of death by using linear regression analysis. Lastly, they emphasized that in order to prove underlying sepsis at the time of death beyond any reasonable doubt, combinations of several biomarkers of sepsis should be recommended.
Groselj-Grenc et al. [40] and Pavcnik-Arnol et al. [45, 47] compared the diagnostic accuracy of LBP and other biochemical markers, including PCT, in differentiating bacterial sepsis from non-bacterial SIRS in critically ill neonates and children, concluding that LBP was a better marker of sepsis than PCT in neonates. The study herein presented is the first analysis assessing the diagnostic value of LBP and PCT for the postmortem detection of sepsis as well as the first study to compare pericardial fluid PCT and LBP levels.
The results of our investigations indicate high diagnostic accuracy for both parameters, individually considered and combined, in detecting sepsis-related outcomes in the postmortem period. It is known that LBP levels may increase after extensive cardiothoracic surgical procedures and decrease after death due to the onset of postmortem phenomena [24, 25] . Similarly, numerous non-septic situations can be characterized by increased PCT values [7, 8, [10] [11] [12] [13] [14] [15] [16] [17] . Our findings indicate that increases in both postmortem serum PCT and LBP levels may corroborate the existence of underlying septic states.
Though further studies and investigations are required to confirm these findings, the results of our data analysis also indicate that pericardial fluid LBP levels do not correlate with the presence of increased postmortem serum LBP levels, in contrast with pericardial fluid PCT levels, which have been shown to correlate well with postmortem serum values.
No associations were identified between postmortem serum and pericardial fluid LBP levels in either septic or nonseptic groups, nor between pericardial fluid PCT and LBP levels. Hence, the determination of LBP in pericardial fluid cannot be considered an alternative to postmortem serum in situations in which postmortem biochemistry could help in determining the cause of death and neither peripheral nor cardiac blood are available upon autopsy.
